These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 24964660)

  • 41. [Aspects of the antimicrobial resistence profile in infections with Escherichia coli and Klebsiella pneumoniae in diabetic patients].
    Petrovici CG; Dorobăţ C; Matei M; Teodor A; Luca V; Miftode E
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):769-75. PubMed ID: 22046785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of carbapenemases, ESBLs, and plasmid-mediated quinolone determinants in carbapenem-insensitive Escherichia coli and Klebsiella pneumoniae in Riyadh hospitals.
    Al-Agamy MH; Aljallal A; Radwan HH; Shibl AM
    J Infect Public Health; 2018; 11(1):64-68. PubMed ID: 28462854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carbapenem resistance in
    Jaggi N; Chatterjee N; Singh V; Giri SK; Dwivedi P; Panwar R; Sharma AP
    Acta Microbiol Immunol Hung; 2019 Sep; 66(3):367-376. PubMed ID: 31438725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular characterisation and epidemiological investigation of an outbreak of blaOXA-181 carbapenemase-producing isolates of Klebsiella pneumoniae in South Africa.
    Jacobson RK; Manesen MR; Moodley C; Smith M; Williams SG; Nicol MP; Bamford CM
    S Afr Med J; 2015 Nov; 105(12):1030-5. PubMed ID: 26792160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections.
    Ben-David D; Kordevani R; Keller N; Tal I; Marzel A; Gal-Mor O; Maor Y; Rahav G
    Clin Microbiol Infect; 2012 Jan; 18(1):54-60. PubMed ID: 21722257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden.
    Samuelsen Ø; Naseer U; Tofteland S; Skutlaberg DH; Onken A; Hjetland R; Sundsfjord A; Giske CG
    J Antimicrob Chemother; 2009 Apr; 63(4):654-8. PubMed ID: 19218573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of plasmid-mediated AmpC β-lactamase in Escherichia coli and Klebsiella pneumoniae.
    Yilmaz NO; Agus N; Bozcal E; Oner O; Uzel A
    Indian J Med Microbiol; 2013; 31(1):53-9. PubMed ID: 23508430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic characterisation of CTX-M-15-producing Klebsiella pneumoniae and Escherichia coli strains isolated from stem cell transplant patients in Tunisia.
    Abbassi MS; Torres C; Achour W; Vinué L; Sáenz Y; Costa D; Bouchami O; Ben Hassen A
    Int J Antimicrob Agents; 2008 Oct; 32(4):308-14. PubMed ID: 18620848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A nationwide study of mechanisms conferring reduced susceptibility to extended-spectrum cephalosporins in clinical Escherichia coli and Klebsiella spp. isolates.
    Tofteland S; Dahl KH; Aasnæs B; Sundsfjord A; Naseer U
    Scand J Infect Dis; 2012 Dec; 44(12):927-33. PubMed ID: 22991975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
    Cai JC; Zhou HW; Zhang R; Chen GX
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2014-8. PubMed ID: 18332176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge.
    Navarro-San Francisco C; Mora-Rillo M; Romero-Gómez MP; Moreno-Ramos F; Rico-Nieto A; Ruiz-Carrascoso G; Gómez-Gil R; Arribas-López JR; Mingorance J; Paño-Pardo JR
    Clin Microbiol Infect; 2013 Feb; 19(2):E72-9. PubMed ID: 23231088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular and epidemiological analysis of nosocomial carbapenem-resistant Klebsiella spp. using repetitive extragenic palindromic-polymerase chain reaction and matrix-assisted laser desorption/ionization-time of flight.
    Treviño M; Navarro D; Barbeito G; García-Riestra C; Crespo C; Regueiro BJ
    Microb Drug Resist; 2011 Sep; 17(3):433-42. PubMed ID: 21568752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae strains isolated between 2004-2007 in Ankara University Hospital, Turkey].
    Us E; Tekeli A; Arikan Akan O; Dolapci I; Sahin F; Karahan ZC
    Mikrobiyol Bul; 2010 Jan; 44(1):1-10. PubMed ID: 20455393
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The mechanism of high-level carbapenem resistance in Klebsiella pneumoniae: underlying Ompk36-deficient strains represent a threat of emerging high-level carbapenem-resistant K. pneumoniae with IMP-1 β-lactamase production in Japan.
    Sho T; Muratani T; Hamasuna R; Yakushiji H; Fujimoto N; Matsumoto T
    Microb Drug Resist; 2013 Aug; 19(4):274-81. PubMed ID: 23514607
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular characterization of integrons in clinical isolates of betalactamase-producing Escherichia coli and Klebsiella pneumoniae in Iran.
    Zeighami H; Haghi F; Hajiahmadi F
    J Chemother; 2015 Jun; 27(3):145-51. PubMed ID: 24571248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro activity of ertapenem and other carbapenems against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey.
    Kiremitci A; Dinleyici EC; Erben N; Durmaz G; Yargic ZA; Aybey AD; Usluer G
    Expert Opin Pharmacother; 2008 Jun; 9(9):1441-9. PubMed ID: 18518776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand.
    Netikul T; Kiratisin P
    PLoS One; 2015; 10(9):e0139116. PubMed ID: 26407326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors for extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae acquisition in a neonatal intensive care unit.
    Shakil S; Ali SZ; Akram M; Ali SM; Khan AU
    J Trop Pediatr; 2010 Apr; 56(2):90-6. PubMed ID: 19608665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prevalence of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae from Daejeon].
    Ko CS; Sung JY; Koo SH; Kwon GC; Shin SY; Park JW
    Korean J Lab Med; 2007 Oct; 27(5):344-50. PubMed ID: 18094599
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of Qnr determinants among bloodstream isolates of Escherichia coli and Klebsiella pneumoniae in a Taiwanese hospital, 1999-2005.
    Wu JJ; Ko WC; Wu HM; Yan JJ
    J Antimicrob Chemother; 2008 Jun; 61(6):1234-9. PubMed ID: 18356152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.